Personal profile


Professor Ian Davis MB BS PhD FRACP FAChPM is a medical oncologist, cancer immunologist, clinician-scientist, and NHMRC Practitioner Fellow. He is Professor of Medicine, Monash University and Eastern Health, and Head of the Eastern Health Clinical School (EHCS), where he is responsible for all clinical research within Eastern Health through the Monash Eastern Clinical Research Unit (ECRU). He holds honorary appointments with the Olivia Newton-John Cancer Research Institute (formerly Ludwig Institute for Cancer Research) and Austin Health, and is an Associate Professor of the University of Melbourne, and Associate of the University of Sydney. His primary clinical interests are in urologic cancer and in melanoma, and his primary research interests are in cancer immunology and the biology of urologic cancers. He heads the Uro-oncology Laboratory at EHCS in which basic and translational research occurs in prostate cancer, and leads the Eastern Health genitourinary cancer clinical trial program. Prof Davis is the founder of the Urologic Oncology Group of the Clinical Oncology Society of Australia (COSA), member of COSA Council, and previously COSA Board director. He is founder of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Ltd (ANZUP). He is chair of the ANZUP Board and of its Scientific Advisory Committee. Prof Davis has published over 220 papers, attracted over $24M in grant funding, and been involved in over 175 clinical trials for which he was global or site Principal Investigator in over 100.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2021

Research Output 2003 2017

BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned

Hayne, D., Stockler, M. R., McCombie, S. P., Lawrence, N., Martin, A., Sengupta, S. & Davis, I. D. 1 May 2017 In : BJU International. 119, p. 55-57 3 p.

Research output: Other - peer-reviewComment / Debate

Challenges of data sharing: valuable but costly?

Davis, I. D. 1 Jan 2017 In : Lancet Oncology. 18, 1, p. 15-16 2 p.

Research output: Other - peer-reviewComment / Debate

Development of indicators to assess quality of care for prostate cancer

Nag, N. , Millar, J. , Davis, I. D. , Costello, S. , Duthie, J. B. , Mark, S. , Delprado, W. , Smith, D. , Pryor, D. , Galvin, D. , Sullivan, F. , Murphy, Á. C. , Roder, D. , Elsaleh, H. , Currow, D. , White, C. , Skala, M. , Moretti, K. L. , Walker, T. , De Ieso, P. & 5 others Brooks, A., Heathcote, P., Frydenberg, M., Thavaseelan, J. & Evans, S. M. 2017 (Accepted/In press) In : European Urology Focus. p. 1-7 7 p.

Research output: Research - peer-reviewArticle

Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category

Davis, I. D., Xie, W., Pezaro, C., Donskov, F., Wells, J. C., Agarwal, N., Srinivas, S., Yuasa, T., Beuselinck, B., Wood, L. A., Ernst, D. S., Kanesvaran, R., Knox, J. J., Pantuck, A., Saleem, S., Alva, A., Rini, B. I., Lee, J-L., Choueiri, T. K. & Heng, D. Y. C. 1 Jun 2017 In : European Urology. 71, 6, p. 970-978 9 p.

Research output: Research - peer-reviewArticle

Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study

Papa, N. P., MacInnis, R. J., English, D. R., Bolton, D., Davis, I. D., Lawrentschuk, N., Millar, J. L., Pedersen, J., Severi, G., Southey, M. C., Hopper, J. L. & Giles, G. G. Aug 2017 In : Urologic Oncology: Seminars and Original Investigations. 35, 8, p. 530.e7-530.e13 7 p.

Research output: Research - peer-reviewArticle